Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update
VANCOUVER, British Columbia & DALLAS — Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that it will report its second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, at 4:30 p.m. ET, after market close. The company will issue a […]
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
